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Objective. To clarify the developmental activity of the autonomic nervous system (ANS) of the normal fetus and intrauterine
growth restriction (IUGR) cases using fetal magnetocardiography (FMCG). Subjects and Methods.N o r m a lp r e g n a n c y( n = 35)
and IUGR (n = 12) cases at 28–39 and 32–37 weeks of gestation, respectively, were included in this study. The R-R interval
variability was used to calculate the coeﬃcient of variance (CVRR) and low frequency/high frequency (LF/HF) ratio. Results.T h e
value of CVRR in the normal pregnancy group displayed a slight increasing trend with gestational age. However, no such trend
was observed in the IUGR group. In contrast, the LF/HF ratio in both the normal pregnancy group and the IUGR group clearly
increased over the gestationalperiod; the normalgroup showingstatisticalsigniﬁcance.Conclusion. The developmentoffetal ANS
activity in IUGR cases might diﬀer from that observed in the normal pregnancy group, and this may facilitate early detection of
IUGR.
1.Introduction
Intrauterine growth restriction (IUGR) delays or terminates
intrauterine fetal development; abnormal fetal condition is
displayed as the pregnancy progresses. Numerous factors
are involved in IUGR. Besides the frequently encountered
high-risk cases of pregnancies and parturitions, neurological
complications and fetal mortalities are also known to corre-
late closely with IUGR [1–6]; therefore, early detection and
causativereferenceofIUGRarecriticalinassessing fetalwell-
being. Although deﬁcient in certain aspects, routine fetal
monitoring is currently performed using ultrasonography
and cardiotocography. Magnetocardiography (MCG) is a
safe and noninvasive method that employs a superconduct-
ing quantum interference device (SQUID) to facilitate a 3-
dimensional analysis of the micromagnetic ﬁeld (10−12 tesla)
generated by phenomenal electric activities of the heart.
Recent applications of fetal MCG (FMCG) have yielded
detailsofacquiredQTprolongationsyndrome,supraventric-
ular tachycardia, and various fetal arrhythmias [7–14].
Attention has recently been focused on spectral analysis
of heart rate variability as a method for evaluating fetal well-
being; for example, the eﬃcacy of analyses of the coeﬃcient
of R-R interval variability (CVRR), low-frequency (LF) and
high-frequency (HF) domains, and the LF/HF ratio in a
supine resting posturehavebeensuggestedfor theevaluation
of autonomic nervous system (ANS) activities [15, 16]. The
methods of ultrasonography and cardiotocography, which
are incapable of measuring CVRR, LF/HF ratio, and various
fetal heart rate variability analyses, can be improved with
FMCG, thereby enabling these indices to be determined.
We previously reported that sympathetic nervous activity
increased with gestational age in the normal pregnancy [17].
In the present study, we evaluated the actual autonomic
nervous system development of normal fetuses at 28–37
weeks of gestation. In the present study, diﬀerences of actual2 Journal of Pregnancy
Table 1: Descriptive characteristics of normal and intrauterine growth restricted (IUGR) fetuses.
Item Normal fetuses (n = 35) (max–min) IUGR fetuses (n = 12) (max–min) P value
Maternal age (years) 31.7 ±6.46 (44–20) 30.9 ±5.79 (42–23) NS
Gestational age (weeks) 33.9 ±3.49 (39–28) 35.2 ±1.80 (37–32) NS
Values are represented as the mean ± SD. NS: not signiﬁcant.
64-channel SQUID sensor
Bed
Figure 1: A monitoring device for magnetocardiography (MCG)
incorporating a 64-channel SQUID apparatus in a magnetically
shielded room.
autonomic nervous system development between normal
and IUGR cases were compared using FMCG.
2.Materialsand Methods
2.1. Subjects. Subjects enrolled in the present study were
women with normal pregnancies (n = 35) at 28–39 weeks
of gestation and those with IUGR (n = 12) at 32–37 weeks
of gestation that visited our hospital as either outpatients or
inpatients between January 2004 and July 2005 (Table 1).
In the normal pregnancy group, fetuses were born at term
and without any abnormal neurological signs. In the IUGR
group, ultrasonography was performed by several specialists
for all cases who underwent FMCG. All of these cases
presented with asymmetrical IUGR with weight 10% less
than normal values; none had complications at birth.
Written informed consent was obtained from all subjects
after being briefed about the clinical study, which was
approvedbytheEthicsCommitteeoftheSchoolofMedicine,
Iwate Medical University (H14-33, H17-2).
2.2. Equipment. To obtain FMCG measurements, pregnant
volunteers assumed a supine position on a bed and were
scanned with a 64-channel MCG sensor (prototype made
by the Joint Research Project for Regional Intensive in Iwate
Prefecture; SQUID sensor, Hitachi High-Technology Co.
Ltd., Tokyo, Japan) installed in a magnetically shielded room
(Figure 1). The position of the fetus was determined with
ultrasonography, using the navel and pubic symphysis as
reference coordinates (Figures 2(a) and 2(b)). The magnetic
ﬁeld in the z direction (Bz) adjacent to the body surface was
monitoredcontinuouslyfor5minutes.Atotaloftwoorthree
measurements were obtained in this manner. Because the
detectedBzisasummationofsignalsfromfetalandmaternal
sources, the maternal QRS waveform was subtracted from
the detected Bz to derive the actual Bz value. Fetal heart
rhythm (approximately 700 beats) was measured for 5
minutes, and the average heart rate was used to derive the
FMCGineachcase(Figure2(c)).The initialandtermination
values of PQ, QRS, and QT were deﬁned by the maximum
points of the ﬁrst derivate of dF/dt (Figure 3). CVRR was
calculated as follows:
Standard deviation (SD) =

1
n
n 
i=1

Di −M
2
,
CVRR =
SD
M
× 100(%),
(1)
where n and Di represent the number of R-R intervals and
the mean of approximately 700 R-R intervals, respectively,
and M represents the total mean of the respective Di.
The power spectrum in the frequency domain was
derived from frequency-ﬁeld components using the maxi-
mum entropy method of fetal heart rate variability. Based
on frequency analysis, the ranges of the LF and HF domains
were deﬁned as 0.01–0.15 and 0.15–0.4Hz, respectively. The
respectivepowervalueswerederivedtoyieldtheLF/HFratio.
Note that the LF/HF ratio is taken as a sympathetic activity
of ANS [18, 19].
2.3. Statistical Analysis. Data were analyzed using StatView
for Windows Ver. 5.0 (SAS Institute Inc., Cary, NC, USA).
The relationships among CVRR, LF/HF, and gestational age
in each group were analyzed by linear regression, while
intergroup changes in CVRR and LF/HF over the gestational
period in each group were veriﬁed by one-way ANOVA.
Changes in CVRR and LF/HF over the gestational period
between normal pregnancy and the IUGR groups were
analyzed by two-way ANOVA.
3.Results
The normal pregnancy group was divided into three groups
for classifying one-way ANOVA analysis of CVRR and LF/HF
asfollows: Group (A):28–31weeksofpregnancy (8th month
of pregnancy); Group (B): 32–35 weeks of pregnancy (9thJournal of Pregnancy 3
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Figure 2: Method of fetal magnetocardiography (FMCG). The position of the fetus was referenced using standard coordinates at the navel
region and pubic symphysis (a). Detected magnetic ﬁeld signals, which comprised signals derived from both the mother and fetus, were
subtracted from the maternally derived QRS waveform (b). In performing FMCG, a total of 300–500 heartbeats detected per determination
were summated to yield the mean (c).
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Figure 3: Determination of PQ, QRS, and QT intervals by diﬀerentiation. In performing FMCG, a total of 300–500 heartbeats detected per
determination were summated to yield the mean. The initial and termination points of the PQ, QRS, and T wave were deﬁned by the ﬁrst
derivate of dF/dt.4 Journal of Pregnancy
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Figure 4: Correlation between the coeﬃcient of variance (CVRR)
and gestational age in normal pregnancy and in IUGR (normal
pregnancy: •—; IUGR: ◦...).
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Figure 5: Intergroup changes in the coeﬃcient of variance (CVRR)
during normal pregnancy. Group (A): 28–31 weeks of pregnancy;
Group (B): 32–35 weeks of pregnancy; Group (C): 36–40 weeks of
pregnancy. One-way ANOVA: P = 0.28 [17].
month of pregnancy); Group (C): 36–40 weeks of pregnancy
(10th month of pregnancy).
The value of CVRR in normal pregnancy showed a
slight increased trend with gestational age (y = 1.77 +
0.10x; r = 0.32) (Figure 4). In contrast, the value of
CVRR in the IUGR group showed no such trend (Figure 4).
Intergroup changes in CVRR over the gestational age periods
in normal pregnancy showed no statistical diﬀerence by one-
way ANOVA [17]( F i g u r e5).
The value of LF/HF in both the normal pregnancy group
and the IUGR group showed an increase with gestational
age (y = 0.19 + 0.04x, r = 0.49; y = 0.16 + 0.04x,
r = 0.23, resp.) (Figure 6). Intergroup changes in LF/HF
in the normal group increased signiﬁcantly according to
the gestation period (one-way ANOVA: P = 0.003) [17]
(Figure 7). There was no statistical diﬀerence in intergroup
y = 0.19+0.04x; r = 0.49 (normal)
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Figure 6: Correlation between the low frequency/high frequency
(LF/HF) ratio and gestational age in normal pregnancy and IUGR.
(Normal pregnancy, •—; IUGR, ◦...).
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Figure 7: Intergroup changes in the low frequency/high frequency
(LF/HF) ratio during normal pregnancy. Group (A): 28–31 weeks
of pregnancy; Group (B): 32–35 weeks of pregnancy; Group (C):
36–40 weeks of pregnancy. ∗One-way ANOVA: P = 0.003 [17].
changes for the LF/HF ratio between normal pregnancy and
IUGR groups.
4.Discussion
Recent advances in medical electronics have enabled various
fetal parameters in the ﬁeld of perinatal medicine to
be obtained in greater detail and with higher precision.
Current improved versions of ultrasonography devices can
provide detailed evaluation regarding morphology and/or
blood ﬂow dynamics. To assess fetal ANS function, Shields
and Schifrin evaluated fetal heart rate variability derived
from fetal cardiotocography and respiratory movements
[20]. More than 90% of fetal asphyxia cases were detected
by abnormal heartbeat patterns using cardiotocography.
Thus, cardiotocography is an indispensable tool that isJournal of Pregnancy 5
routinelyemployedinclinicalobstetrics;however,evenwhen
abnormal heartbeat patterns are detected, the combined
use of ultrasonic Doppler and biophysical proﬁle analy-
sis does not improve the ability to identify undiagnosed
cases of asphyxia. These conventional methods are yet to
objectively and reliably evaluate functional development of
the fetal autonomic nervous system; they are also unable
to consistently achieve prenatal diagnosis of conditions
that result from abnormal fetal autonomic nervous system
development, such as cerebral palsy. As a result, unnecessary
obstetric interventions are encountered, and the rate of
cesarean section continues to increase without any decrease
in the incidenceof fetal central nervoussystem impairments,
especially cerebral palsy. This problem indicates the need for
a novel method for prenatal diagnosis [21, 22].
In the present study, we developed an FMCG by
modifying our recently developed 64-channel MCG [23,
24]. The special features of MCG make it possible for
the device to perform a 3-dimensional analysis of the
magnetic ﬁeld generated by the phenomenal electric activ-
ities of the heart in both fetuses and adults. FMCG is
an extremely safe and noninvasive method for monitoring
fetal cardiac activities [8]. To date, numerous studies have
used FMCG to analyze fetal arrhythmias [11, 13, 14, 25–
27]. Although analyses of heart rate variability have been
attempted on fetal autonomic nervous system functions
using FMCG, little has been established using this technique
[28, 29].
In the present study, FMCG signals were generally too
weak to enable a precise analysis of fetal ANS activity to
be performed prior to 28 week of pregnancy in the normal
pregnancy group and prior to 32 weeks of pregnancy in the
IUGR group. To advance the development of this method,
we undertook the following studies: (i) elucidation of the
developmental stages of the fetal autonomic nervous system
over a period of 39 weeks and (ii) comparison of FMCG
ﬁndings between normal pregnancy and IUGR groups. In
IUGR cases, both the diﬀerence in fetal size and other
obstetric risks are higher, and the correlation dimension
decreaseswhencompared with thenormal pregnancy group;
that is, the heart rate coordination system is nonversatile and
highly susceptible to stress [30, 31]. In brief, it is critical to
diﬀerentiate on grounds of perinatal management whether
a fetus has low body weight alone or whether it also has
endogenous functional issues.
According to our previous study [17], the result of
measurements attempted on CVRR, a value that reﬂects
parasympathetic nervous system (PSN) activity [15, 16],
indicated that CVRR values exhibited a slight increasing
trend with gestational age in the normal pregnancy group.
In addition, we deﬁned a value of the LF/HF ratio as the
sympathetic nervous system (SNS) activity or balancing
factor between the SNS and the PNS activities [29]. The
LF/HF ratio showed a clear increase with gestational age
in the normal pregnancy group [17]. It is understood that
fetal ANS function develops as gestation progresses [29].
These results are consistent with ultrasound analyses of
the fetal mouthing movement interval and eye-movement
phase patterns, in which major changes are seen to occur
at around gestational weeks 28–33 [31]. This evidence from
earlier studies is consistent with the results of the present
study. Our results revealed that the maturation process,
especially in SNS activity or the balancing factor between
SNS and PNS activities, changes dramatically from 28–39
weeks gestation. For the fetus, therefore, it is very important
to avoid preterm delivery, not only in terms of body size and
organic maturation but also for the functional development
of ANS.
A previous study obtained by frequency analysis using
FMCG indicated decreased complexity and increased peri-
odicity of the LF and HF ranges in IUGR cases [27]. In the
present study, the value of the LF/HF ratio in the IUGR
group tended to increase with gestational age; however, the
value of CVRR did not show a clear trend. This ﬁnding
might depend on growth restriction or heterogeneity in
termsofetiologyandseverityintheIUGRcases[32].Further
investigation of IUGR cases, along with detailed analyses of
patient background, is therefore required. The development
pattern of ANS in the fetal period may become one of
the important indices for prenatal management in the near
future.
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